Skip to main content
OpenTrials
Completed

NCT Number: NCT05006924

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Haukeland University Hospital, Bergen, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Genetically confirmed Myotonic Dystrophy type 1

Exclusion criteria

  • Unable to answer or understand questionnaires due to language barriers or cognitive status
  • Unable to perform functional tests

Treatment and study plan

Primary outcomes

  1. Motor Function Measures (MFM)

    Time frame: 30-45 minutes

    Functional test

  2. Nine Hole Peg Test

    Time frame: 1-3 minutes

    Fine motor function test

  3. Myogrip/Dynamometer

    Time frame: 1-3 minutes

    Measures hand strenght

  4. Myopinch

    Time frame: 1-3 minutes

    Measures finger strenght

  5. ABILHAND Questionnaire

    Time frame: 5 min

    A measure of manual ability for adults with upper limb impairments. The scale measures a person's ability to manage daily activities that require the use of the upper limbs, whatever the strategies involved. Consists of 22 questions (18 to be answered by adults). The categories are easy, difficult or unable to perform. The querionnaire gives a sum score where higher score equals better function.Score from 0 to 36

  6. ACTIVLIM Questionnaire

    Time frame: 5 min

    A measure of activity limitations for patients with upper and/or lower limb impairments. The scale measures a patient's ability to perform daily activities requiring the use of the upper and/or the lower limbs, whatever the strategies involved. Consists of 22 questions (18 to be answered by adults). The categories are easy, difficult or unable to perform. The questionnaire gives a sum score where higher score equals better function. Score fror 0 to 36

Secondary outcomes

  1. Trunk Impairment Scale - modified Norwegian version

    Time frame: 8-15 minutes

    Motor impairment of trunk measured by functional testing. Six subdomains measuring stability and mobility of trunkal movement. Min score 0 - Max score 16. Higher score indicates better function.

  2. Four Square Step Test

    Time frame: 1-3 minutes

    Dynamic balance test

  3. PROMIS29

    Time frame: 5-10 minutes

    This a compostie measurement that is a Questionnaire. Patient reported outcome measure. Generic health related quality of life assesses each of the 7 PROMIS domains (depresseion, anxiety, physical function, pain, fatigue, sleep disturbance and ability to participate in social roles). The PROMIS 29 questionnaire contains 4 questions from each of seven PROMIS contents (physical function, depression, anxiety, fatigue, sleep disorder, participation in social activities and pain interaction) and 1 question from the intensity of pain. Each item has 5 answer options (from 1 to 5), only pain intensity has 11 answer options (from 0 to 10). From the sum of the answers to each question in the domain, the total raw score for each domain is calculated, resulting in seven domain scores, each between 4 and 20.

  4. Starkstein Apathy Scale

    Time frame: 5 minutes

    Questionnaire to be filled in under guidance of interviewer. Patient reported outcome measure of apathy. 14 questions, each of which is scored on a 4-point scale of 0-3, and apathy is rated as severer as the total score (0-42) increases

  5. Montreal Cognitive Assessment (MoCA)

    Time frame: 10 minutes

    Cognitive assessment screening questionnaire. To be filled out in an interview setting. Score from 0 to 30, where a higher score indicates a better cognitive function. A score of 26 or more is considered normal.

  6. Lung function test

    Time frame: 10 minutes

    Spirometry with FVC (Forced Vital Capasity)

  7. Lung function test

    Time frame: 10 minutes

    PEF (Peak Expiratory Flow).

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Haukeland University Hospital
  • University of Oslo

Registry information

Acronym: SOUL-DM1

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Aug 16, 2021
Registry last updated
Apr 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.